Women and opioids: something different is happening here

The Lancet

Volumn 392, Issue 10141, 2018, Pages 9-11

  Mazure, Carolyn M ^a   Fiellin, David A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; DISULFIRAM; FENTANYL; METHADONE; NALTREXONE; OPIATE; NARCOTIC AGENT;

ALCOHOLISM; CHILD HEALTH; CHRONIC PAIN; DISEASE EXACERBATION; DRUG DEPENDENCE; DRUG USE; FETAL WELL BEING; HEADACHE; HUMAN; MATERNAL WELFARE; MORTALITY RATE; NEONATAL ABSTINENCE SYNDROME; NOTE; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; ADULT; AGED; CANADA; CAUSALITY; CULTURAL FACTOR; DRUG OVERDOSE; EPIDEMIC; FEMALE; LIFE EVENT; MIDDLE AGED; OPIATE ADDICTION; PSYCHOLOGY; RISK FACTOR; SEX FACTOR; UNITED STATES;

ADULT; AGED; CANADA; CAUSALITY; CHRONIC PAIN; CROSS-CULTURAL COMPARISON; DRUG OVERDOSE; EPIDEMICS; FEMALE; HUMANS; LIFE CHANGE EVENTS; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; RISK FACTORS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85049479879     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)31203-0     Document Type: Note

References (23)

1. Humphreys, K, Avoiding globalization of the prescription opioid epidemic. Lancet 390 (2017), 437–439.
2. Kolodny, A, Frieden, TR, Ten steps the federal government should take now to reverse the opioid epidemic. JAMA 318 (2017), 1537–1538.
3. Fillingam, RB, King, CD, Ribero-Dasilva, MC, Rahim-Williams, B, Riley, JL III, Sex, gender, and pain. J Pain 10 (2009), 447–485.
4. Bartley, EJ, Fillingim, RB, Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 111 (2013), 52–58.
5. Hirschtritt, ME, Delucchi, KL, Olfson, M, Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993–2014. Prev Med Rep 21 (2017), 49–54.
6. Cicero, TJ, Wong, G, Tian, Y, Lynskey, M, Todotov, A, Isenberg, K, Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database. Pain 144 (2009), 20–27.
7. Hwang, CS, Kang, EM, Kornegay, CJ, Staffa, JA, Jones, CM, McAninch, JK, Trends in the concomitant prescribing of opioids and benzodiazepines, 2002–2014. Am J Med 51 (2016), 151–160.
8. National Institute on Drug Abuse. Overdose death rates. https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates, September, 2017. (Accessed 20 April 2018)
9. Martin, CE, Longinaker, N, Terplan, M, Recent trends in treatment admissions for prescription opioid abuse during pregnancy. J Subst Abuse Treat 48 (2015), 37–42.
10. Unger, A, Jung, E, Winklbaur, B, Fischer, G, Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. J Addict Dis 29 (2010), 217–230.
11. Bodnar, RJ, Kest, B, Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones. Hormones Behav 58 (2011), 72–81.
12. McHugh, RK, DeVito, EE, Dodd, D, et al. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat 45 (2013), 38–43.
13. Han, B, Compton, WM, Blanco, C, Crane, E, Lee, J, Jones, CM, Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann Intern Med 167 (2017), 293–301.
14. Hernandez-Avila, CA, Rounsaville, BJ, Kranzler, HR, Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alc Depend 74 (2004), 265–272.
15. Greenfield, SF, Brooks, AJ, Gordon, SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alc Depend 86 (2007), 1–21.
16. McHugh, RK, Votaw, VR, Sugarman, DE, Greenfield, SF, Sex and gender differences in substance use disorders. Clin Psychol Rev, 2017 published online Nov 10. https://doi.org/10.1016/j.cpr.2017.10.012.
17. Bawor, M, Dennis, BB, Bhalerao, et al. Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review. CMAJ 3 (2015), E344–E351.
18. Grella, CE, Karno, MP, Warda, US, Niv, N, Moore, AA, Gender and comorbidity among individuals with opioid use disorder in the NESARC study. Addict Behav 34 (2009), 498–504.
19. Stringer, KL, Baker, EH, Stigma as a barrier to substance abuse treatment among those with unmet need: an analysis of parenthood and marital status. J Fam Issues 39 (2018), 3–27.
20. Grella, CE, From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs(suppl 5), 2008, 327–343.
21. DeVito, EE, Babuscio, TA, Nich, C, Ball, SA, Carroll, KM, Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram. Drug Alcohol Depend 1 (2014), 156–167.
22. Clarke, TK, Crist, RC, Ang, A, et al. Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. Pharmacogenomics J 14 (2014), 303–308.
23. Sumner, SA, Mercado-Crespo, MC, Spelke, MB, et al. Use of naloxone by emergency medical services during opioid drug overdose resuscitation efforts. Prehosp Emerg Care 20 (2016), 220–225.